表紙:組織バンクの世界市場 - 市場規模、シェア、見通し、市場機会の分析 2018年~2026年
市場調査レポート
商品コード
865077

組織バンクの世界市場 - 市場規模、シェア、見通し、市場機会の分析 2018年~2026年

Tissue Banking Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 152 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.86円
組織バンクの世界市場 - 市場規模、シェア、見通し、市場機会の分析 2018年~2026年
出版日: 2019年05月06日
発行: Coherent Market Insights
ページ情報: 英文 152 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

外科手術における同種移植の需要、股関節置換術における骨移植片の需要、大腿骨骨頭の同種移植の需要、熱傷患者の増加などによって、組織バンク市場の成長が促進されています。

当レポートでは、世界の組織バンク市場を調査し、市場の概要、製品・組織タイプ・地域・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 仮定
  • 略語

第2章 市場の概要

  • レポート概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場スニペット:製品別
    • 市場スニペット:組織タイプ別
    • 市場スニペット:地域別
  • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、動向分析

  • マーケットダイナミクス
    • 成長要因
    • 阻害要因
    • 市場機会
  • 影響分析
  • 市場動向
  • 主な開発
  • 技術の進歩
  • サプライチェーン分析
  • 規制の状況
  • PEST分析

第4章 世界の組織バンク市場:製品別

  • イントロダクション
  • 媒体・消耗品
  • 装置

第5章 世界の組織バンク市場:組織タイプ別

  • イントロダクション
  • 脳・脊髄
  • 角膜
  • 心臓弁
  • その他

第6章 世界の組織バンク市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • 中南米
  • アフリカ
  • 中東

第7章 競争環境

  • ヒートマップ解析
  • 企業プロファイル
    • AbD Serotec
    • AMS Biotechnology Limited
    • BioLife Solutions, Inc.
    • Beckman Coulter, Inc.
    • BioCision LLC
    • BioStorage Technologies, Inc.
    • Custom BioGenic Systems
    • Eppendorf AG
    • EMD Millipore Corporation
    • Fisher BioServices, Inc.
    • Genzyme Corporation
    • Hamilton Company
    • Merck KGaA
    • PHC Corporation
    • Teva Pharmaceutical Industries Ltd.
  • アナリストの意見

第8章 セクション

  • 参考文献
  • 調査方法
  • Cohrenet Market Insightsについて
目次

Tissue banks recover, process, store, and distribute tissue for transplantation. Research in the field of tissue preservation at low temperature and high clinical success of transplanted tissue led to increase in the use of stored tissue in major burn and trauma patients. Increased demand for allografts resulted in the establishment of in-house tissue banking activity at major burns centers. Tissue banking organization is a complex system and needs high technical expertise and skilled personnel for proper functioning in a dedicated facility.

Market Dynamics

Increasing surgical demands for allografts, demand for bone graft in hip replacements, and femoral head allografts, and increasing incidences of burn patients are the main factors for the growth of the tissue banking market. According to WHO March 2018 report, about 180,000 deaths are caused by burns every year, majority of the cases occur in low and middle income countries. Moreover, aging population is prone to chronic diseases, such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy.

Private and public organizations are playing crucial role in fulfilling the gap between demand and supply of tissue. For instance, in 2017, MTF Biologics distributed over 550,000 tissue grafts, which was made possible through the selfless donation by 5,700 individuals. These transplantable tissues helped to heal an estimated 400,000 lives in over 50 countries.

Dearth of highly trained professionals to maintain the tissue banks is the major restraining factor for growth of the tissue banking market. For instance, according to ALZFORUM 2018 report, over the last 50 years, the number of neuropathologists on staff at the Netherlands Brain Bank dropped from 65 to about 15.

Key features of the study:

  • This report provides in-depth analysis of the tissue banking market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global tissue banking market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological upgradation, market expansion, and marketing tactics
  • The global tissue banking market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for tissue banking market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Tissue Banking Market, By Product:
  • Media and Consumables
  • Equipment
    • Cryopreservation Equipment
    • Quality Control Equipment
    • Thawing equipment
    • Others
  • Global Tissue Banking Market, By Tissue Type:
  • Bone
  • Brain & Spinal Cord
  • Cornea
  • Heart Valves
  • Skin
  • Others
  • Global Tissue Banking Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
    • By Product:
  • Media and Consumables
  • Equipment
  • Cryopreservation Equipment
  • Quality Control Equipment
  • Thawing equipment
  • Others
    • By Tissue Type:
  • Bone
  • Brain & Spinal Cord
  • Cornea
  • Heart Valves
  • Skin
  • Others
  • Europe
    • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
    • By Product:
  • Media and Consumables
  • Equipment
  • Cryopreservation Equipment
  • Quality Control Equipment
  • Thawing equipment
  • Others
    • By Tissue Type:
  • Bone
  • Brain & Spinal Cord
  • Cornea
  • Heart Valves
  • Skin
  • Others
  • Asia Pacific
    • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
    • By Product:
  • Media and Consumables
  • Equipment
  • Cryopreservation Equipment
  • Quality Control Equipment
  • Thawing equipment
  • Others
    • By Tissue Type:
  • Bone
  • Brain & Spinal Cord
  • Cornea
  • Heart Valves
  • Skin
  • Others
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
    • By Product:
  • Media and Consumables
  • Equipment
  • Cryopreservation Equipment
  • Quality Control Equipment
  • Thawing equipment
  • Others
    • By Tissue Type:
  • Bone
  • Brain & Spinal Cord
  • Cornea
  • Heart Valves
  • Skin
  • Others
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
    • By Product:
  • Media and Consumables
  • Equipment
  • Cryopreservation Equipment
  • Quality Control Equipment
  • Thawing equipment
  • Others
    • By Tissue Type:
  • Bone
  • Brain & Spinal Cord
  • Cornea
  • Heart Valves
  • Skin
  • Others
  • Africa
    • By Country:
  • South Africa
  • Central Africa
  • North Africa
    • By Product:
  • Media and Consumables
  • Equipment
  • Cryopreservation Equipment
  • Quality Control Equipment
  • Thawing equipment
  • Others
    • By Tissue Type:
  • Bone
  • Brain & Spinal Cord
  • Cornea
  • Heart Valves
  • Skin
  • Others
  • Company Profiles
  • AbD Serotec*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • AMS Biotechnology Limited
  • BioLife Solutions, Inc.
  • Beckman Coulter, Inc.
  • BioCision LLC
  • BioStorage Technologies, Inc.
  • Custom BioGenic Systems
  • Eppendorf AG
  • EMD Millipore Corporation
  • Fisher BioServices, Inc.
  • Genzyme Corporation
  • Hamilton Company
  • Merck KGaA
  • PHC Corporation
  • Teva Pharmaceutical Industries Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product
    • Market Snippet, By Tissue Type
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technological Advancements
  • Supply Chain Analysis
  • Regulatory Landscape
  • PEST Analysis

4. Global Tissue Banking Market, By Product, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Media and Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
    • Cryopreservation Equipment
    • Quality Control Equipment
    • Thawing Equipment
    • Others

5. Global Tissue Banking Market, By Tissue Type, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Bone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Brain and Spinal Cord
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Cornea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Heart Valves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Tissue Banking Market, By Region, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2016 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Tissue Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Tissue Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Tissue Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Tissue Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Tissue Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Product, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Tissue Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • AbD Serotec
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • AMS Biotechnology Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BioLife Solutions, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Beckman Coulter, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BioCision LLC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BioStorage Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Custom BioGenic Systems
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Eppendorf AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • EMD Millipore Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Fisher BioServices, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Genzyme Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Hamilton Company
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • PHC Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact